PL374481A1 - Środek do leczenia cukrzycy - Google Patents
Środek do leczenia cukrzycyInfo
- Publication number
- PL374481A1 PL374481A1 PL03374481A PL37448103A PL374481A1 PL 374481 A1 PL374481 A1 PL 374481A1 PL 03374481 A PL03374481 A PL 03374481A PL 37448103 A PL37448103 A PL 37448103A PL 374481 A1 PL374481 A1 PL 374481A1
- Authority
- PL
- Poland
- Prior art keywords
- ghs
- antagonist
- active ingredient
- prophylactic
- therapeutic
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 102000000393 Ghrelin Receptors Human genes 0.000 abstract 5
- 108010016122 Ghrelin Receptors Proteins 0.000 abstract 5
- 239000005557 antagonist Substances 0.000 abstract 4
- 239000004480 active ingredient Substances 0.000 abstract 3
- 230000000069 prophylactic effect Effects 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 239000002830 appetite depressant Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF] (Somatoliberin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002197582 | 2002-07-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL374481A1 true PL374481A1 (pl) | 2005-10-31 |
Family
ID=30112403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03374481A PL374481A1 (pl) | 2002-07-05 | 2003-07-03 | Środek do leczenia cukrzycy |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20060276381A1 (pl) |
| EP (1) | EP1541171B1 (pl) |
| JP (1) | JP5113320B2 (pl) |
| KR (1) | KR20050039829A (pl) |
| CN (1) | CN1681532A (pl) |
| AT (1) | ATE481133T1 (pl) |
| AU (1) | AU2003246261A1 (pl) |
| BR (1) | BR0312463A (pl) |
| CA (1) | CA2493906A1 (pl) |
| DE (1) | DE60334225D1 (pl) |
| ES (1) | ES2351856T3 (pl) |
| MX (1) | MXPA05000160A (pl) |
| PL (1) | PL374481A1 (pl) |
| RU (1) | RU2005102923A (pl) |
| WO (1) | WO2004004772A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006090767A1 (ja) * | 2005-02-23 | 2006-08-31 | Kyoto University | 膵臓β細胞の再生促進剤及び膵臓β細胞におけるインスリン産生促進剤 |
| US8536120B2 (en) | 2006-04-28 | 2013-09-17 | The Administrators Of The Tulane Educational Fund | Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof |
| WO2008111573A1 (ja) | 2007-03-12 | 2008-09-18 | Snow Brand Milk Products Co., Ltd. | 成長ホルモン分泌促進剤 |
| CN101951937A (zh) * | 2007-12-21 | 2011-01-19 | 赫尔辛医疗股份公司 | 使用伊帕瑞林刺激胃肠系统动力的方法 |
| WO2010022213A2 (en) * | 2008-08-22 | 2010-02-25 | Elixir Pharmaceuticals, Inc. | Compositions and methods for preserving pancreatic islet mass |
| US9724381B2 (en) | 2009-05-12 | 2017-08-08 | The Administrators Of The Tulane Educational Fund | Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof |
| JP2013506687A (ja) | 2009-09-30 | 2013-02-28 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | オートファジー促進遺伝子産物の変調によりオートファジーを変調する方法 |
| CA2778990A1 (en) | 2009-10-30 | 2011-05-05 | Tranzyme Pharma, Inc. | Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010020012A1 (en) * | 2000-02-01 | 2001-09-06 | Andersen Maibritt Bansholm | Use of compounds for the regulation of food intake |
| AU2001228325A1 (en) * | 2000-02-01 | 2001-08-14 | Novo-Nordisk A/S | Use of compounds for the regulation of food intake |
| AU2001259056A1 (en) * | 2000-05-17 | 2001-11-26 | Eli Lilly And Company | Method for selectively inhibiting ghrelin action |
| CA2411667A1 (en) * | 2000-05-30 | 2001-12-06 | Merck & Co. Inc. | Ghrelin analogs |
| WO2002060472A1 (en) * | 2001-01-31 | 2002-08-08 | Chugai Seiyaku Kabushiki Kaisha | Remedies for hyponutrition status |
| US6949261B2 (en) * | 2002-11-12 | 2005-09-27 | Ayurvedic-Life International, Llc | Compositions for diabetes treatment and prophylaxis |
-
2003
- 2003-07-03 RU RU2005102923/15A patent/RU2005102923A/ru not_active Application Discontinuation
- 2003-07-03 WO PCT/JP2003/008482 patent/WO2004004772A1/ja active Application Filing
- 2003-07-03 KR KR1020057000174A patent/KR20050039829A/ko not_active Application Discontinuation
- 2003-07-03 PL PL03374481A patent/PL374481A1/pl unknown
- 2003-07-03 JP JP2004519256A patent/JP5113320B2/ja not_active Expired - Fee Related
- 2003-07-03 MX MXPA05000160A patent/MXPA05000160A/es unknown
- 2003-07-03 CN CNA038211610A patent/CN1681532A/zh active Pending
- 2003-07-03 BR BR0312463-0A patent/BR0312463A/pt not_active Application Discontinuation
- 2003-07-03 AU AU2003246261A patent/AU2003246261A1/en not_active Abandoned
- 2003-07-03 EP EP03738666A patent/EP1541171B1/en not_active Expired - Lifetime
- 2003-07-03 AT AT03738666T patent/ATE481133T1/de not_active IP Right Cessation
- 2003-07-03 ES ES03738666T patent/ES2351856T3/es not_active Expired - Lifetime
- 2003-07-03 DE DE60334225T patent/DE60334225D1/de not_active Expired - Lifetime
- 2003-07-03 CA CA002493906A patent/CA2493906A1/en not_active Abandoned
- 2003-07-03 US US10/520,327 patent/US20060276381A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003246261A1 (en) | 2004-01-23 |
| US20060276381A1 (en) | 2006-12-07 |
| ES2351856T3 (es) | 2011-02-11 |
| CA2493906A1 (en) | 2004-01-15 |
| RU2005102923A (ru) | 2005-10-10 |
| JP5113320B2 (ja) | 2013-01-09 |
| DE60334225D1 (de) | 2010-10-28 |
| ATE481133T1 (de) | 2010-10-15 |
| EP1541171A4 (en) | 2008-04-09 |
| JPWO2004004772A1 (ja) | 2005-11-04 |
| MXPA05000160A (es) | 2006-02-28 |
| KR20050039829A (ko) | 2005-04-29 |
| WO2004004772A1 (ja) | 2004-01-15 |
| BR0312463A (pt) | 2005-04-26 |
| EP1541171A1 (en) | 2005-06-15 |
| EP1541171B1 (en) | 2010-09-15 |
| CN1681532A (zh) | 2005-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20060908L (no) | Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse | |
| ZA200706021B (en) | 1-thio-D-glucitol derivatives | |
| YU75903A (sh) | Tiohidantoini i njihovo korišćenje u lečenju dijabetisa | |
| IN2015DN01132A (pl) | ||
| WO2004072031A3 (en) | Phenylacetamides and their use as glucokinase modulators | |
| EG24124A (en) | Pharmaceutical compositions for the treatment of type-II diabetes mellitus | |
| NO20072389L (no) | Substituerte benzokinolizinderivater | |
| NO20065926L (no) | Substituerte oksazolbenzoisotiazoldioksidderivater samt fremgangsmate for fremstilling og anvendelse derav | |
| WO2007065808A3 (en) | Neuropeptide-2 receptor-agonists | |
| NO20055680L (no) | Heksahydropyridoisokinoliner som DPP-IV-inhibitorer | |
| IL179599A0 (en) | Glucagon receptor antagonists, preparation and therapeutic uses | |
| WO2005082893A3 (en) | Histamine h3 receptor antagonists, preparation and therapeutic uses | |
| DK1675591T3 (da) | Farmaceutisk sammensætning omfattende en monoamin-neurotransmitter-genoptagelseshæmmer og en acetylcholinesterase-hæmmer | |
| WO2008136392A1 (ja) | 経口投与用製剤 | |
| AU2003289156A1 (en) | Preventive or remedy for diseases caused by hyperglycemia | |
| WO2002042271A3 (en) | Biphenylcarboxamides useful as lipid lowering agents | |
| PL374481A1 (pl) | Środek do leczenia cukrzycy | |
| JO2390B1 (en) | Diphenylcarboxamides act as lipid-lowering agents | |
| WO2004026837A3 (en) | Histamine h3 receptor antagonists, preparaton and therapeutic uses | |
| NO20054168L (no) | Substituerte 3-(benzoylureido)-tiofenderivater, fremgangsmate for fremstilling og anvendelse derav | |
| WO2004024066A3 (en) | Method of treating diabetes and related conditions | |
| PT1414453E (pt) | Polimorfo de cloridrato de fexofenadina | |
| NO20063860L (no) | 7-fenylamino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav samt deres anvendelse som legemidler | |
| WO2003089449A3 (fr) | Composes aminoalkylsteroles avec activite anti-tumeur et neuroprotective | |
| TWI256952B (en) | Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |